Evidence map›Paper›PMID 31293189›Full record

ReviewExpert review of clinical immunology2019

Neonatal vaccine effectiveness and the role of adjuvants.

Isaac G Sakala, Katherine Marie Eichinger, Nikolai Petrovsky

Open access · greenAbstract readReview
In one paragraph

Review in Expert review of clinical immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Early-life microbiota-immune homeostasis.Frontiers in immunology · 2023
    Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Isaac G Sakalaa Vaxine Pty Ltd , Adelaide , Australia.
Katherine Marie Eichingerc Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, University of Pittsburgh , Pittsburgh , PA , USA.
Nikolai Petrovskya Vaxine Pty Ltd , Adelaide , Australia.
Flinders Medical Centre · AUUniversity of Pittsburgh · USVaxine (Australia) · AU

Funding

NRSA Training CoreTL1TR001858 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI RADOMSKI, THOMAS, RUBIO, DORIS M · 2016 to 2025
$11.1M
Novel vaccine adjuvants to counter bioterrorist threatsU01AI061142 · NIAID · FLINDERS UNIVERSITY OF SOUTH AUSTRALIA · PI PETROVSKY, NIKOLAI · 2005 to 2009
$3.5M
NCATS NIH HHS TL1 TR001858NIAID NIH HHS HHSN272200800039CNIAID NIH HHS HHSN272201400053CNIAID NIH HHS U01 AI061142
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

VaccinationAdjuvants, Immunologicbeta-GlucansGlycolipidsHumansImmune SystemImmunity, InnateInfant, NewbornInulinVaccinesAdjuvants, Immunologicbeta-Glucanscurdlandelta inulinGlycolipidsInulintrehalose 6,6'-dibehenateVaccinesadjuvantAdvaxcarbohydratedelta inulinimmunityinfluenzaNeonatevaccine

Identifiers

PMID31293189
PMCPMC6678067
OpenAlexW2956933320

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.